Photo of Chandler Park from ukhealthcare.uky.edu
Sep 18, 2024, 15:00
Chandler Park: SunRise-1 study ESMO24 update
Chandler Park shared a post on X:
“SunRise-1 study ESMO24 update.
TAR-200 +/- cetrelimab in patients with BCG-unresponsive high risk nonmuscle bladder cancer 83.5% CR in TAR-200 arm.
Great honor to be PI in Kentucky w/Dr. Ryan Malone on this pivotal study.”
Source: Chandler Park/X
Chandler Park, MD, FACP is an haematologist oncologist, medical journalist, and clinical researcher. He is the Advisory Dean and Clinical Professor at University of Louisville School of Medicine. He is the Kentucky Physician Representative of the ASCO State Executive Council. He is also the Medical Oncology Board Examiner at American Board of Internal Medicine.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 21, 2024, 22:40
Dec 21, 2024, 22:37
Dec 21, 2024, 22:26
Dec 21, 2024, 19:39
Dec 21, 2024, 19:21
Dec 21, 2024, 19:19